Cardiopulmonary Bypass Pumps Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Cardiopulmonary Bypass Pumps Market Size

Cardiopulmonary Bypass Pumps Market size is projected to depict substantial CAGR from 2024 to 2032, attributed to the rising prevalence of cardiovascular diseases (CVDs) on a global scale. Conditions like coronary artery disease, valvular heart disease, and congenital heart defects have consistently remained significant contributors to morbidity and mortality. With aging population, sedentary lifestyles, and dietary shifts adding to the growing incidence of these conditions, there is a corresponding surge in the demand for cardiac interventions and surgeries. For instance, in November 2023, Medtronic plc launched its penditure left atrial appendage (LAA) exclusion system in the U.S., specifically designed for managing the LAA during concurrent cardiac surgery procedures.
 

However, the high cost of equipment, concerns about potential complications during bypass procedures, and the increasing preference for minimally invasive alternatives may hamper the industry growth to some extent in the forecast period.
 

Cardiopulmonary Bypass Pumps Market Trends

Rapid technological advancements, such as the development of miniaturized and portable bypass pumps for enhancing surgical procedures will add to the industry expansion. The increasing prevalence of cardiovascular diseases and the rising aging population are leading to the growing demand for cardiac surgeries. The gradual shift towards minimally invasive procedures is also resulting in the higher integration of advanced monitoring systems in bypass pumps. Additionally, the increasing collaborations between healthcare institutions and manufacturers for R&D activities for focusing on improving pump efficiency and patient outcomes.
 

Cardiopulmonary Bypass Pumps Market Analysis

The lung transplant operations segment is expected to rise significantly up to 2032. Cardiopulmonary bypass pumps are increasingly used in en-bloc and double-bloc lung transplantation driven by the surging number of transplantation procedures performed each year. The increasing prevalence of chronic respiratory diseases and the growing concerns associated with pulmonary failures will propel the demand for advanced pulmonary pumps.
 

Hospitals are projected to account for substantial share of the cardiopulmonary bypass pumps industry by 2032. Hospitals are investing heavily in modern cardiopulmonary bypass devices as they enable continuous monitoring of temperature, circuit pressure, and blood parameters to ensure safety. Due to the growing patient pool of cardiovascular diseases and the massive healthcare spending worldwide, several private and public initiatives are helping hospitals deploy next-generation medical equipment and machines for better patient outcomes, further adding to the product uptake.
 

North America cardiopulmonary bypass pumps market size is set to expand at a substantial rate from 2024-2032 driven by the increasing prevalence of cardiovascular illnesses. According to the Centre for Disease Control and Prevention, cardiovascular disease stands as the primary cause of death for men, women, and individuals across diverse racial and ethnic groups in the U.S. Every 33 seconds, one person succumbs to cardiovascular disease in the country. The U.S. and Canada are also placing hefty investments in extensive research activities to boost innovations and technological advancements along with collaborations among healthcare companies. Moreover, the presence of supportive government initiatives and favorable reimbursement policies will also fuel industry expansion across the region.
 

Cardiopulmonary Bypass Pumps Market Share

Some of the major cardiopulmonary bypass pumps companies are:

• Olympus Corporation
• Terumo Corporation
• LivaNova
• Medtronic
• Maquet (Getinge)
• BraileBiomedica
   

Leading companies involved in the cardiopulmonary bypass pumps industry are shifting their focus on launching new products with enhanced features to gain a higher market ground. For instance, LivaNova, PLC is a U.K.-based medical device manufacturer, specialized in developing devices for cardiac surgery and neuromodulation.
 

Cardiopulmonary Bypass Pumps Industry News:

• In April 2022, LivaNova commenced the target commercial launch of ‘Essenz’, a patient monitor specifically designed for cardiopulmonary bypass procedures. This advanced monitoring system adopts a patient-tailored approach to improve clinical efficiency and enhance the quality of patient care during cardiopulmonary bypass (CPB) procedures.

What Information does this report contain?